title: Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?
authors.forename: Nathalie
authors.initials: N
authors.lastname: Costedoat-Chalumeau
authors.forename: Gaelle
authors.initials: G
authors.lastname: Leroux
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Piette
authors.forename: Zahir
authors.initials: Z
authors.lastname: Amoura
mesh_terms: D018501:Antirheumatic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D006886:Hydroxychloroquine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D018570:Risk Assessment
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine